Plasmin Generation Analysis in Patients with Bleeding Disorder of Unknown Cause.

IF 7.4 1区 医学 Q1 HEMATOLOGY
Dino Mehic, Stéphanie E Reitsma, Claire de Moreuil, Helmuth Haslacher, Maximilian Christian Koeller, Bas de Laat, Cihan Ay, Ingrid Pabinger, Alisa Wolberg, Johanna Gebhart
{"title":"Plasmin Generation Analysis in Patients with Bleeding Disorder of Unknown Cause.","authors":"Dino Mehic, Stéphanie E Reitsma, Claire de Moreuil, Helmuth Haslacher, Maximilian Christian Koeller, Bas de Laat, Cihan Ay, Ingrid Pabinger, Alisa Wolberg, Johanna Gebhart","doi":"10.1182/bloodadvances.2024012855","DOIUrl":null,"url":null,"abstract":"<p><p>Bleeding disorder of unknown cause (BDUC) is a diagnosis of exclusion after evaluation of plasma coagulation and platelet function. The underlying mechanisms are unclear, but increased fibrinolysis and abnormal clot formation may play a role. All BDUC patients (n=375) from the Vienna bleeding biobank were analyzed in comparison to healthy controls (HC, n=100) in this case-control study. Plasmin generation (PG) parameters were analyzed using calibrated fluorescence detection in citrated-plasma samples. Turbidimetric plasma clot formation/ lysis of 293 (78%) BDUC patients and confocal microscopy of clots from representative BDUC patients (n=6) and HC (n=9) were assessed. Fibrinolytic factors were measured using commercially available ELISAs. In PG analysis, BDUC patients exhibited lower velocity and peak plasmin, but a higher endogenous plasmin potential compared to HC. Peak plasmin correlated with maximum clot absorbance, but not with clot lysis time. Clot absorbance is an indicator of clot fiber density. Confocal microscopy analysis revealed that BDUC patients' clots had a tendency towards thicker fibers, which negatively correlated with peak plasmin (r=-0.561, p=0.030). Peak plasmin correlated weakly with FXIII, but not with the other fibrinolytic factors (alpha2-antiplasmin, thrombin activatable fibrinolysis inhibitor or plasminogen activator inhibitor 1) or bleeding severity. A model comprising fibrinogen and parameters of PG yielded high predictive power in discriminating BDUC patients from HC during 5-fold stratified cross validation (80% of data, mean AUC: 0.847). The same model generalized well to unseen data (20% of data, AUC: 0.856). Overall, BDUC patients exhibited counterintuitively reduced peak plasmin, potentially related to altered clot structure.</p>","PeriodicalId":9228,"journal":{"name":"Blood advances","volume":null,"pages":null},"PeriodicalIF":7.4000,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood advances","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1182/bloodadvances.2024012855","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Bleeding disorder of unknown cause (BDUC) is a diagnosis of exclusion after evaluation of plasma coagulation and platelet function. The underlying mechanisms are unclear, but increased fibrinolysis and abnormal clot formation may play a role. All BDUC patients (n=375) from the Vienna bleeding biobank were analyzed in comparison to healthy controls (HC, n=100) in this case-control study. Plasmin generation (PG) parameters were analyzed using calibrated fluorescence detection in citrated-plasma samples. Turbidimetric plasma clot formation/ lysis of 293 (78%) BDUC patients and confocal microscopy of clots from representative BDUC patients (n=6) and HC (n=9) were assessed. Fibrinolytic factors were measured using commercially available ELISAs. In PG analysis, BDUC patients exhibited lower velocity and peak plasmin, but a higher endogenous plasmin potential compared to HC. Peak plasmin correlated with maximum clot absorbance, but not with clot lysis time. Clot absorbance is an indicator of clot fiber density. Confocal microscopy analysis revealed that BDUC patients' clots had a tendency towards thicker fibers, which negatively correlated with peak plasmin (r=-0.561, p=0.030). Peak plasmin correlated weakly with FXIII, but not with the other fibrinolytic factors (alpha2-antiplasmin, thrombin activatable fibrinolysis inhibitor or plasminogen activator inhibitor 1) or bleeding severity. A model comprising fibrinogen and parameters of PG yielded high predictive power in discriminating BDUC patients from HC during 5-fold stratified cross validation (80% of data, mean AUC: 0.847). The same model generalized well to unseen data (20% of data, AUC: 0.856). Overall, BDUC patients exhibited counterintuitively reduced peak plasmin, potentially related to altered clot structure.

原因不明的出血性疾病患者的凝血酶生成分析
原因不明的出血性疾病(BDUC)是对血浆凝固和血小板功能进行评估后的排除性诊断。其潜在机制尚不清楚,但纤维蛋白溶解增加和血块形成异常可能是其中的一个原因。在这项病例对照研究中,对维也纳出血生物库中的所有 BDUC 患者(人数=375)与健康对照组(人数=100)进行了对比分析。使用校准荧光检测法对柠檬酸化血浆样本中的凝血酶生成(PG)参数进行了分析。对 293 名(78%)BDUC 患者的血浆凝块形成/溶解情况进行了浊度测定,并对具有代表性的 BDUC 患者(6 人)和 HC(9 人)的凝块进行了共聚焦显微镜检查。纤溶因子采用市售的酶联免疫吸附试验进行测定。在 PG 分析中,与 HC 相比,BDUC 患者表现出较低的速度和血浆蛋白峰值,但内源性血浆蛋白电位较高。血浆蛋白峰值与血块最大吸光度相关,但与血块溶解时间无关。血块吸光度是血块纤维密度的指标。共聚焦显微镜分析显示,BDUC 患者的血块纤维有变粗的趋势,这与血浆蛋白峰值呈负相关(r=-0.561,p=0.030)。血浆蛋白峰值与 FXIII 呈弱相关,但与其他纤溶因子(α2-抗蛋白酶、凝血酶活化纤溶抑制因子或纤溶酶原激活物抑制因子 1)或出血严重程度无关。在 5 倍分层交叉验证过程中,由纤维蛋白原和 PG 参数组成的模型在区分 BDUC 患者和 HC 患者方面具有很高的预测能力(80% 的数据,平均 AUC:0.847)。同一模型对未见过的数据也有很好的通用性(20% 的数据,AUC:0.856)。总体而言,BDUC 患者的血浆蛋白峰值降低与直觉相反,这可能与血块结构的改变有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Blood advances
Blood advances Medicine-Hematology
CiteScore
12.70
自引率
2.70%
发文量
840
期刊介绍: Blood Advances, a semimonthly medical journal published by the American Society of Hematology, marks the first addition to the Blood family in 70 years. This peer-reviewed, online-only, open-access journal was launched under the leadership of founding editor-in-chief Robert Negrin, MD, from Stanford University Medical Center in Stanford, CA, with its inaugural issue released on November 29, 2016. Blood Advances serves as an international platform for original articles detailing basic laboratory, translational, and clinical investigations in hematology. The journal comprehensively covers all aspects of hematology, including disorders of leukocytes (both benign and malignant), erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology. Each article undergoes a rigorous peer-review process, with selection based on the originality of the findings, the high quality of the work presented, and the clarity of the presentation.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信